Nivolumab (Opdivo) will be listed on the PBS from 1 August for head and neck squamous cell carcinoma The listing, announced in advance by Federal minister for Health Greg Hunt, means almost 1,000 patients will get subsidised access to the immunotherapy drug they would otherwise have to pay about $50,000 per year for. On 11 ...
Four oncology drugs get PBS listings on 1 August
By Mardi Chapman
18 Jul 2018